EX-10.17 4 dex1017.htm PROCESS DEVELOPMENT AND MFG SERVICES AGREEMENT - LONZA BIOLOGICS, INC. [*] = Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been...Process Development and Manufacturing Services Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of March 28, 2008 (the “Effective Date”), by and between Bayhill Therapeutics, Inc., a Delaware corporation (“Client”), and Lonza Biologics, Inc., a Delaware corporation (“LONZA”) (each, a “Party” and together the “Parties”).
Process Development and Manufacturing Services Agreement by and between Bayhill Therapeutics, Inc. and Lonza Biologics, Inc.Process Development and Manufacturing Services Agreement • May 12th, 2008 • Bayhill Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 12th, 2008 Company Industry JurisdictionThis Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of March 28, 2008 (the “Effective Date”), by and between Bayhill Therapeutics, Inc., a Delaware corporation (“Client”), and Lonza Biologics, Inc., a Delaware corporation (“LONZA”) (each, a “Party” and together the “Parties”).